INT7111

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.56
First Reported 1992
Last Reported 1996
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 0.50
Pain Relevance 0.86

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (SLC6A12) plasma membrane (SLC6A12) transmembrane transport (SLC6A12)
SLC6A12 (Homo sapiens)
Pain Link Frequency Relevance Heat
Migraine 2 97.72 Very High Very High Very High
headache 6 96.00 Very High Very High Very High
epidural 3 92.20 High High
agonist 1 90.36 High High
antagonist 1 89.32 High High
tetrodotoxin 1 68.40 Quite High
Disease Link Frequency Relevance Heat
Migraine Disorders 2 97.72 Very High Very High Very High
Headache Disorders 1 83.04 Quite High
Headache 4 79.68 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Its method of action is believed to be the inhibition of gamma-aminobutyric acid transaminase.
Negative_regulation (inhibition) of gamma-aminobutyric acid transaminase
1) Confidence 0.56 Published 1996 Journal Headache Section Abstract Doc Link 8824009 Disease Relevance 0.50 Pain Relevance 0.59
The inhibition of gamma-aminobutyric acid-transaminase with ethanolamino-O-sulphate seemed to be a suitable procedure for enhancing the gamma-aminobutyric acid efflux without interfering with its autoreceptor-mediated negative feedback, tested with the gamma-aminobutyric acid agonist (+/-)baclofen and antagonist phaclofen.
Negative_regulation (inhibition) of gamma-aminobutyric associated with antagonist and agonist
2) Confidence 0.05 Published 1992 Journal Neurochem. Int. Section Abstract Doc Link 1338898 Disease Relevance 0 Pain Relevance 0.27

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox